Back to 
JANE STREET GROUP, LLC
JANE STREET GROUP, LLC
PMCBShowing 3 of 5 quarters
Position history for JANE STREET GROUP, LLC's holdings in PHARMACYTE BIOTECH INC
Yes. Jane Street Group holds 30,064 shares of PMCB (Pharmacyte Biotech), worth $23,149, as of its Q2 2026 13F filing. It increased the position by 18,534 shares (+160.8%) from Q1 2026. Jane Street Group has held PMCB since Q4 2025, across 3 quarterly 13F filings.
Current Value
$23,149
Current Shares
30,064
Total Value Change
+$14,902
Total Shares Change
+18,673
Quarter-by-Quarter History
Other major holders of PMCB: GEODE CAPITAL MANAGEMENT, LLC